Avadel Pharmaceuticals plc (AVDL) NASDAQ

15.15

-0.1236(-0.81%)

Updated at October 01 02:54PM

Currency In USD

Valuation

Market Cap999.93M
Enterprise Value950.26M
P/E Ratio-501.21
PEG Ratio-5.65
Price/Sales Ratio6.61
Price/Book Ratio16.15
Enterprise/Revenue6.34
Enterprise/EBITDA210.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.01
Operating Margin0.01

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue169.12M
Revenue/Share2.29
Gross Profit153.84M
EBITDA-35.57M
Net Income-48.83M
Diluted EPS-0.51

Balance Sheet

Total Cash81.55M
Total Cash/Share0.84
Total Debt2.73M
Total Debt/Equity0.03
Current Ratio2.79
Book Value Per Share0.94

Price History

52-Week Change15.09
52-Week High16.66
52-Week Low6.38
Moving Average 50 Days13.91
Moving Average 200 Days10.13

Statistics

Average Volume1.29M
Shares Outstanding96.5M
% Held by Institutions83.44

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A